(S)-3,5-DICHLORO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-6-HYDROXY-O-ANISAMIDE
Traumatic Brain Injury
National Institute of Neurological Disorders and Stroke (NINDS)Small moleculePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 73/ 100
Competitive context
93 Active assets in the Traumatic Brain Injury cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MELATONIN Children's National Research Institute | Phase 4 | BBB |
Valproic Acid Northwestern University | Phase 4 | BBB |
PROPRANOLOL Tanta University | Phase 4 | BBB |
NEPENTHE Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 4 | BB |
N-Acetyl-L-Cysteine HonorHealth Research Institute | Phase 2 | BB |
View all 50 →
Same molecule, other indications
(S)-3,5-DICHLORO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-6-HYDROXY-O-ANISAMIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →